CIK 0002091349 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
First Tracks Biotherapeutics, Inc.
Sign in to watch- Ticker
- TRAX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 395003207
- Phone
- 212-373-3000
- Business address
- 10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
- Former names
- Biopharma Company, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,758,145
- in 1 filing
Net −$1,758,145. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-01 | STONE BENJAMIN Chief Business Officer | Grant or award · Common Stock | +42,500 | 42,500 | ||
| 2026-11-01 | Tamboli Ajim Chief Financial Officer | Grant or award · Common Stock | +42,500 | 42,500 | ||
| 2026-11-01 | Lizzul Paul F. Chief Medical Officer | Grant or award · Common Stock | +42,500 | 42,500 | ||
| 2026-11-01 | Faga Daniel President, CEO | Grant or award · Common Stock | +136,000 | 136,000 | ||
| 2026-09-15 | Orwin John A Director | Option exercise | +1,300 | 17,995 | ||
| 2026-09-15 | Orwin John A Director | Option exercise · Restricted Stock Unit | −1,300 | 0 | ||
| 2026-09-02 | Ware J. Anthony Director | Option exercise | +39,265 | $5.74 | $225K | 54,925 |
| 2026-09-02 | Ware J. Anthony Director | Sale | −39,265 | $44.78 | $1.8M | 15,660 |
| 2026-09-02 | Ware J. Anthony Director | Option exercise · Stock Option (right to buy) | −28,571 | 0 | ||
| 2026-09-02 | Ware J. Anthony Director | Option exercise · Stock Option (right to buy) | −10,694 | 0 | ||
| 2026-08-15 | STONE BENJAMIN Chief Business Officer | Grant or award · Performance Stock Units | +60,492 | 137,651 | ||
| 2026-08-15 | Lizzul Paul F. Chief Medical Officer | Grant or award · Performance Stock Units | +60,492 | 137,651 | ||
| 2026-08-15 | Faga Daniel President, CEO | Grant or award · Performance Stock Units | +193,575 | 440,485 | ||
| 2026-08-02 | STONE BENJAMIN Chief Business Officer | Grant or award · Performance Stock Units | +60,492 | 77,159 | ||
| 2026-08-02 | Lizzul Paul F. Chief Medical Officer | Grant or award · Performance Stock Units | +60,492 | 77,159 | ||
| 2026-08-02 | Faga Daniel President, CEO | Grant or award · Performance Stock Units | +193,576 | 387,156 | ||
| 2026-06-15 | Ware J. Anthony Director | Option exercise | +6,030 | 15,660 | ||
| 2026-06-15 | Ware J. Anthony Director | Option exercise · Restricted Stock Unit | −6,030 | 0 | ||
| 2026-06-15 | Jain Rita Director | Option exercise | +7,330 | 19,194 | ||
| 2026-06-15 | Jain Rita Director | Option exercise · Restricted Stock Unit | −6,030 | 0 |
Page 1 of 8 · 151 trades